Sector revisions Highnoon Laboratories Limited

Stocks

End-of-day quote Pakistan S.E. 2026-08-19			5-day change	1st Jan Change
983.09 ^PKR	-0.63%		-1.19%	-3.85%

05-18	Highnoon Laboratories Appoints Dr. Shahzad Khan as Managing Director of Highnoon Life Sciences	CI
04-30	Highnoon Laboratories Limited Approves Final Cash Dividend for the Year Ended December 31, 2025	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
HIGHNOON LABORATORIES LIMITED	-	-	-	-	1
ELI LILLY AND COMPANY					28
JOHNSON & JOHNSON					22
ABBVIE INC.					29
ROCHE HOLDING AG					18
NOVARTIS AG					21
ASTRAZENECA PLC					22
AMGEN INC.					29
NOVO NORDISK A/S					24
GILEAD SCIENCES, INC.					27
PFIZER INC.					26
BRISTOL-MYERS SQUIBB COMPANY					24
VERTEX PHARMACEUTICALS INCORPORATED					25
SANOFI					23
GSK PLC					20
CHUGAI PHARMACEUTICAL CO., LTD.					15
TAKEDA PHARMACEUTICAL COMPANY LIMITED					16
BAYER AG					18
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD					16
TEVA PHARMACEUTICAL INDUSTRIES LIMITED					10
Average					21
Weighted average by Cap.					24